Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol plus progesterone for glucose regulation in peri- and early postmenopausal women with diabetes
NL-OMON59966Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol and progesterone in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam University Medical Center. Started Feb 2026; status: recruiting.
02
Drugs
estradiolprogesterone
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON59966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59966.